ERBB2 and breast cancer: In contrast, for breast cancer patients who were not treated with radiotherapy, FHL1 failed to be an independent poor prognostic factor of DFS and OS, although nodal status, grade, oestrogen receptor (ER) and HER2 were independent prognostic factors.